enGene Therapeutics (ENGN) Assets (2022 - 2026)
enGene Therapeutics' Assets came in at $288.32 million for fiscal Q3 2026 (quarter ended Jul 31, 2026), up 17.4% from $245.55 million a year earlier but down 6.2% from the prior quarter.
Powered by 
Analysis
enGene Therapeutics (ENGN) Assets (2022 - 2026) Analysis & Trends
At the end of FY2025 (ended Oct 31, 2025), enGene Therapeutics' Assets was $221.47 million, down 28.8% from FY2024.
- Assets carries a three-year compound annual growth rate of 110.0% (FY2022 to FY2025).
- Going back by fiscal year, Assets was $311.17 million in FY2024 (+257.8%), $86.96 million in FY2023 (+263.7%) and $23.91 million in FY2022.
- The five-year range for quarterly Assets is $23.91 million (fiscal Q4 2022) to $337.11 million (fiscal Q1 2026).
- Year-over-year, Assets has increased for three consecutive quarters, with growth averaging 59.4% over the last eight quarters.
- The fastest year-over-year change in Assets over five years came in fiscal Q4 2023 (growth of 263.7%), and the weakest in fiscal Q4 2025 (a decline of 28.8%).
- Business Quant data shows ENGN's Assets at $307.52 million (Q2 2026), $337.11 million (Q1 2026) and $221.47 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 27.42 Bn |
| 10 | enGene Therapeutics | 130.68 Mn | 130.68 Mn | - | 288.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 288.32 Mn |
| Apr 30, 2026 | 307.52 Mn |
| Jan 31, 2026 | 337.11 Mn |
| Oct 31, 2025 | 221.47 Mn |
| Jul 31, 2025 | 245.55 Mn |
| Apr 30, 2025 | 266.65 Mn |
| Jan 31, 2025 | 285.93 Mn |
| Oct 31, 2024 | 311.17 Mn |
| Jul 31, 2024 | 266.88 Mn |
| Apr 30, 2024 | 273.53 Mn |
| Jan 31, 2024 | 93.42 Mn |
| Oct 31, 2023 | 86.96 Mn |
| Oct 31, 2022 | 23.91 Mn |
API Access
enGene Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();